HOME 研究活動 研究要素集 研究要素集 <検索>慢性腎不全における間質線維化の発現・進展機序の解明

慢性腎不全における間質線維化の発現・進展機序の解明

メンバー: 鈴木和彦

分野: 動物生命科学、基礎医学

所属: 農学研究院

キーワード: 腎臓、線維化、近位尿細管上皮細胞、筋線維芽細胞、上皮間葉転換

ウェブサイト:

研究概要

腎間質線維化は糸球体腎炎などの各種腎疾患に付随して認められる、いわゆる「慢性腎不全」の病態で、進行の度合いが腎機能低下の程度と密接に関わっている。しかし、腎間質線維化には複数の因子が関与しており、機序の解明には未だに課題が多い。腎線維化の病態は尿細管傷害とそれに伴う膠原線維の蓄積に大別され、尿細管傷害が腎機能の中心である老廃物の排出・再吸収の喪失をもたらし、再生時には膠原線維の産生増加及び分解抑制に寄与する因子を産生するようになることを申請者はこれまでに明らかにしてきた。また、近位尿細管は上皮間葉転換により筋線維芽細胞となって直接、膠原線維産生に寄与する可能性も示唆されている。このことから、まず病態初期に惹起される尿細管傷害を最小限に留めることで過剰な線維化の促進を抑制しうると考え、尿細管上皮細胞の形質変化に寄与する機序を中心とした研究を実施している。
 慢性腎不全は日本国内では8人に1人が罹患している疾患で、早期発見・早期治療が可能になりつつあるといわれている。しかし、腎機能が60%未満に低下しないと症状が認められず、線維化が不可逆的な病態であるのも事実である。従って、病態の不可逆点を通過した後に機能低下の速度を低下させる対症療法が現在の医療では主体である点が非常に問題であると考える。また、慢性腎不全は現代社会において医学領域はもちろん、獣医学領域でも特にネコで問題となっている疾患であるため、人医療と獣医療の双方で慢性腎不全の病態改善および新規治療法の開発に対して非常に有益な知見が得られることが期待できる。

主要論文・参考事項

Suzuki K*, Uetsuka K, Nakayama H, Doi C, Doi K. Renal tubulointerstitial lesions in mercuric chloride-treated Brown Norway rats. J. Toxicol. Pathol. 1998; 11(4): 241-247.

Suzuki K*, Uetsuka K, Nakayama H, Doi K. Kinetics of transforming growth factor-beta1 and extracellular matrix in renal tubulointerstitial lesions of mercuric chloride-treated Brown Norway rats. Int. J. Exp. Pathol. 1999; 80(3): 125-32.

Suzuki K*, Nakayama H, Doi K. Renal tubulointerstitial lesions in mercuric chloride-treated F344 rats. J. Toxicol. Pathol. 2000; 13(4): 213-218.

Suzuki K*, Nakayama H, Doi K. Kinetics of matrix metalloproteinases and their regulatory factors in mercuric chloride-induced tubulointerstitial fibrosis in Brown Norway rats. Exp. Toxicol. Pathol. 2001; 53(5): 337-43.

Suzuki K*, Kanabayashi T, Nakayama H, Doi K. Kinetics of chemokines and their receptors in mercuric chloride-induced tubulointerstitial lesions in Brown Norway rats. Exp. Mol. Pathol. 2003; 75(1): 58-67.

Suzuki K*, Kanabayashi T, Nakayama H, Doi K. Effects of tacrolimus and dexamethasone on tubulointerstitial fibrosis in mercuric chloride treated Brown Norway rats. Exp. Toxicol. Pathol. 2003; 55(2-3): 197-208.

Suzuki K*, Wang RS, Kubota H, Shibuya H, Saegusa J, Sato T. Kinetics of biglycan, decorin and thrombospondin-1 in mercuric chloride-indeced renal tubulointerstitial fibrosis. Exp. Mol. Pathol. 2005; 79(1): 68-73.

お問い合わせ先

東京農工大学・先端産学連携研究推進センター
urac[at]ml.tuat.ac.jp([at]を@に変換してください)

研究要素集検索

Pathogenesis of renal interstitial fibrosis in chronic renal failure

Research members: Dr. Kazuhiko Suzuki

Research fields: Animal life science, Basic medicine

Departments: Institute of Agriculture

Keywords: kidney, fibrosis, proximal tubular cells, myofibroblats, epithelial mesenchymal transition

Web site:

Summary

Renal tubulointerstitial fibrosis, i.e chronic renal failure, has been attracting great attention, since it was recognized that renal tubulointerstitial lesions following renal tubular and glomerular injury are closely related with renal dysfunction. Mechanisms of tubulointerstitial fibrosis are considerably intricated and involved many factors. Its mechanism is mainly consisted from tubular injury and following extracellular matrix (ECM) accumulation. We previously reported that tubular injury cause the loss of functions of eject waste matter and reabsorption, and that regenerative proximal tubular cells contribute to secrete the factors that increase ECM production and/or decrease ECM degradation. Moreover, it is suggested that epithelial mesenchymal transition induce the change from proximal tubular cells to myofibroblasts that may contribute to ECM production. From these acknowledgements, we speculate that the inhibition of tubular injury may be effective for repress the excessive fibrosis progression, and investigate about the mechanism of renal tubulointerstitial fibrosis focused on the transformation of proximal tubular cells.
     In Japan, one out of eight people had chronic renal failure, and this disease can be early detection and treatment. However, clinical sign could not find until renal finction decrease less than 60 %, and fibrosis is irreversible.Therefore, it may be the problem that symptomatic treatment to slow the progression speed is the mail treatment for chronic renal failure. Moreover, also in veterinaly field, chronic renal failure is one of the important diseases in cats. Therefore, our investigation may contribule to find important acknowledgement for treatment of chronic renal failure both in medical and veterinaly fields.

Reference articles and patents

Suzuki K*, Uetsuka K, Nakayama H, Doi C, Doi K. Renal tubulointerstitial lesions in mercuric chloride-treated Brown Norway rats. J. Toxicol. Pathol. 1998; 11(4): 241-247.

Suzuki K*, Uetsuka K, Nakayama H, Doi K. Kinetics of transforming growth factor-beta1 and extracellular matrix in renal tubulointerstitial lesions of mercuric chloride-treated Brown Norway rats. Int. J. Exp. Pathol. 1999; 80(3): 125-32.

Suzuki K*, Nakayama H, Doi K. Renal tubulointerstitial lesions in mercuric chloride-treated F344 rats. J. Toxicol. Pathol. 2000; 13(4): 213-218.

Suzuki K*, Nakayama H, Doi K. Kinetics of matrix metalloproteinases and their regulatory factors in mercuric chloride-induced tubulointerstitial fibrosis in Brown Norway rats. Exp. Toxicol. Pathol. 2001; 53(5): 337-43.

Suzuki K*, Kanabayashi T, Nakayama H, Doi K. Kinetics of chemokines and their receptors in mercuric chloride-induced tubulointerstitial lesions in Brown Norway rats. Exp. Mol. Pathol. 2003; 75(1): 58-67.

Suzuki K*, Kanabayashi T, Nakayama H, Doi K. Effects of tacrolimus and dexamethasone on tubulointerstitial fibrosis in mercuric chloride treated Brown Norway rats. Exp. Toxicol. Pathol. 2003; 55(2-3): 197-208.

Suzuki K*, Wang RS, Kubota H, Shibuya H, Saegusa J, Sato T. Kinetics of biglycan, decorin and thrombospondin-1 in mercuric chloride-indeced renal tubulointerstitial fibrosis. Exp. Mol. Pathol. 2005; 79(1): 68-73.

Contact

University Research Administration Center(URAC),
Tokyo University of Agriculture andTechnology
urac[at]ml.tuat.ac.jp
(Please replace [at] with @.)

Search